MX361881B - Prediccion y optimizacion de terapia de potasio en suero para terapia de sangre para insuficiencia renal, especialmente hemodialisis domiciliaria. - Google Patents

Prediccion y optimizacion de terapia de potasio en suero para terapia de sangre para insuficiencia renal, especialmente hemodialisis domiciliaria.

Info

Publication number
MX361881B
MX361881B MX2016002083A MX2016002083A MX361881B MX 361881 B MX361881 B MX 361881B MX 2016002083 A MX2016002083 A MX 2016002083A MX 2016002083 A MX2016002083 A MX 2016002083A MX 361881 B MX361881 B MX 361881B
Authority
MX
Mexico
Prior art keywords
potassium
patient
therapy
serum potassium
hemodialysis
Prior art date
Application number
MX2016002083A
Other languages
English (en)
Spanish (es)
Other versions
MX2016002083A (es
Inventor
Kenneth Leypoldt John
Akonur Alp
Cheng Lo Yin-
Ugar Agar Baris
Original Assignee
Baxter Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US13/969,162 external-priority patent/US9132219B2/en
Application filed by Baxter Int filed Critical Baxter Int
Publication of MX2016002083A publication Critical patent/MX2016002083A/es
Publication of MX361881B publication Critical patent/MX361881B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
    • A61M1/1601—Control or regulation
    • A61M1/1613—Profiling or modelling of patient or predicted treatment evolution or outcome
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
    • A61M1/3403—Regulation parameters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3607—Regulation parameters
    • A61M1/3609—Physical characteristics of the blood, e.g. haematocrit, urea
    • A61M1/361—Physical characteristics of the blood, e.g. haematocrit, urea before treatment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3607—Regulation parameters
    • A61M1/3609—Physical characteristics of the blood, e.g. haematocrit, urea
    • A61M1/3612—Physical characteristics of the blood, e.g. haematocrit, urea after treatment
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/40—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to mechanical, radiation or invasive therapies, e.g. surgery, laser therapy, dialysis or acupuncture
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H70/00—ICT specially adapted for the handling or processing of medical references
    • G16H70/60—ICT specially adapted for the handling or processing of medical references relating to pathologies

Landscapes

  • Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Health & Medical Sciences (AREA)
  • Vascular Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Anesthesiology (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Medical Informatics (AREA)
  • Primary Health Care (AREA)
  • Emergency Medicine (AREA)
  • External Artificial Organs (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
MX2016002083A 2013-08-16 2014-08-08 Prediccion y optimizacion de terapia de potasio en suero para terapia de sangre para insuficiencia renal, especialmente hemodialisis domiciliaria. MX361881B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13/969,162 US9132219B2 (en) 2010-04-16 2013-08-16 Therapy prediction and optimization of serum potassium for renal failure blood therapy, especially home hemodialysis
PCT/US2014/050383 WO2015026542A1 (en) 2013-08-16 2014-08-08 Therapy prediction and optimization of serum potassium for renal failure blood therapy, especially home hemodialysis

Publications (2)

Publication Number Publication Date
MX2016002083A MX2016002083A (es) 2016-06-23
MX361881B true MX361881B (es) 2018-12-18

Family

ID=52484047

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016002083A MX361881B (es) 2013-08-16 2014-08-08 Prediccion y optimizacion de terapia de potasio en suero para terapia de sangre para insuficiencia renal, especialmente hemodialisis domiciliaria.

Country Status (7)

Country Link
EP (2) EP3033704B1 (enExample)
JP (1) JP6477704B2 (enExample)
AU (1) AU2014309285A1 (enExample)
CA (1) CA2919223A1 (enExample)
ES (2) ES2717130T3 (enExample)
MX (1) MX361881B (enExample)
WO (1) WO2015026542A1 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ747822A (en) * 2016-04-15 2022-02-25 Becton Dickinson Co Medical device with anti-rotation push tab
JP6716428B2 (ja) * 2016-11-11 2020-07-01 日機装株式会社 血液浄化治療支援システム
JP6997582B2 (ja) * 2017-10-17 2022-01-17 日機装株式会社 血液浄化装置
JP6914803B2 (ja) * 2017-10-17 2021-08-04 日機装株式会社 血液浄化装置
DE102017130548A1 (de) * 2017-12-19 2019-06-19 Fresenius Medical Care Deutschland Gmbh Verfahren und Vorrichtungen zum Festlegen eines Behandlungsregimes zum Verändern von Behandlungsparametern beim Dialysieren eines Patienten
JP2019212249A (ja) * 2018-06-10 2019-12-12 大 益満 プログラム及び情報処理システム
CN113574607A (zh) * 2019-03-11 2021-10-29 甘布罗伦迪亚股份公司 估计透析患者体内物质的生成率
JP7392126B2 (ja) 2019-10-04 2023-12-05 フレセニウス メディカル ケア ホールディングス インコーポレーテッド 透析プロセス中に患者の血液特性を決定するための技法
WO2023008294A1 (ja) * 2021-07-26 2023-02-02 株式会社ジェイ・エム・エス 透析条件設定支援装置及びプログラム
US20240390564A1 (en) * 2021-09-29 2024-11-28 National University Corporation Shizuoka University Device for providing dialysis information and program for providing dialysis information
WO2024242176A1 (ja) * 2023-05-25 2024-11-28 フィジオロガス・テクノロジーズ株式会社 血液透析治療支援システム

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10339342B3 (de) * 2003-08-25 2005-01-20 Fresenius Medical Care Deutschland Gmbh Blutbehandlungsvorrichtung
JP4548349B2 (ja) * 2006-01-20 2010-09-22 株式会社ジェイ・エム・エス 血液透析装置
US20080253911A1 (en) 2007-02-27 2008-10-16 Deka Products Limited Partnership Pumping Cassette
US20090107335A1 (en) 2007-02-27 2009-04-30 Deka Products Limited Partnership Air trap for a medical infusion device
US9028691B2 (en) 2007-02-27 2015-05-12 Deka Products Limited Partnership Blood circuit assembly for a hemodialysis system
US8042563B2 (en) 2007-02-27 2011-10-25 Deka Products Limited Partnership Cassette system integrated apparatus
US8393690B2 (en) 2007-02-27 2013-03-12 Deka Products Limited Partnership Enclosure for a portable hemodialysis system
US8562834B2 (en) 2007-02-27 2013-10-22 Deka Products Limited Partnership Modular assembly for a portable hemodialysis system
US8168063B2 (en) 2008-07-09 2012-05-01 Baxter International Inc. Dialysis system having filtering method for determining therapy prescriptions
US8062513B2 (en) 2008-07-09 2011-11-22 Baxter International Inc. Dialysis system and machine having therapy prescription recall
US8057679B2 (en) 2008-07-09 2011-11-15 Baxter International Inc. Dialysis system having trending and alert generation
US9514283B2 (en) 2008-07-09 2016-12-06 Baxter International Inc. Dialysis system having inventory management including online dextrose mixing
US7981281B2 (en) 2008-07-09 2011-07-19 Baxter International, Inc. Dialysis system having regimen generation methodology
US9132219B2 (en) * 2010-04-16 2015-09-15 Baxter International Inc. Therapy prediction and optimization of serum potassium for renal failure blood therapy, especially home hemodialysis
AU2011239489B2 (en) * 2010-04-16 2015-04-02 Baxter Healthcare S.A. Therapy prediction and optimization for renal failure blood therapy, especially home hemodialysis

Also Published As

Publication number Publication date
AU2014309285A1 (en) 2016-01-28
MX2016002083A (es) 2016-06-23
ES2653716T3 (es) 2018-02-08
EP3229159B1 (en) 2018-12-26
CA2919223A1 (en) 2015-02-26
ES2717130T3 (es) 2019-06-19
EP3229159A1 (en) 2017-10-11
JP2016535644A (ja) 2016-11-17
WO2015026542A1 (en) 2015-02-26
JP6477704B2 (ja) 2019-03-06
EP3033704A1 (en) 2016-06-22
EP3033704B1 (en) 2017-10-04

Similar Documents

Publication Publication Date Title
MX2016002083A (es) Prediccion y optimizacion de terapia de potasio en suero para terapia de sangre para insuficiencia renal, especialmente hemodialisis domiciliaria.
NZ603010A (en) Therapy prediction and optimization for renal failure blood therapy, especially home hemodialysis
WO2013101292A3 (en) Fluid volume monitoring for patients with renal disease
WO2012135573A3 (en) Systems and methods for varying blood flow to identify autoregulatory ranges in a patient
EP3043875A4 (en) Method to determine body's physiological response to physical exercise for assessing readiness and to provide feedback, and system for implementing the method
SG10201600502XA (en) Methods and kits for predicting the risk of respiratory failure, renal failure or thrombopenia in a septic patient by measuring endocan levels in blood
TN2013000472A1 (en) Induction of immune tolerance by using methotrexate
HUE038959T2 (hu) Eljárás akut légúti distressz szindrómával (ARDS) összefüggõ biomarkerek kimutatására, illetve eljárás az ARDS betegben történõ kifejlõdésének és kezelésének monitorozására
PH12016502150A1 (en) Method for treating renal cell carcimona
WO2012169892A3 (en) The use of alkaline phosphatase for preserving renal function
HK1249583A1 (zh) 作为血液学毒性生物标记之gdf-15
WO2012145399A3 (en) Methods of diagnosing cancer in a patient
MX2015005937A (es) Metodo de tratamiento de la agresion.
MX2014014821A (es) Biomarcadores de plasma sanguineo para terapias de combinacion con bevacizumab para el tratamiento de cancer de mama.
UA62757U (ru) Способ прогнозирования адекватности программного гемодиализа у больных с хронической болезнью почек v стадии
HK1186768A (en) Methods and kits for predicting the risk of respiratory failure, renal failure or thrombopenia in a septic patient by measuring endocan levels in blood
UA91048U (uk) Спосіб лікування антифосфоліпідного синдрому
UA86357U (ru) Способ прогнозирования эффективности лечения больных с синдромом сухого глаза на фоне поствариэктомического синдрома
UA74217U (ru) Способ лечения больных сахарным диабетом II типа
UA62777U (ru) Способ ранней диагностики степени тяжести острой почечной недостаточности разного генеза
UA71607U (ru) Способ прогнозирования эффективности консервативной терапии остеоартроза
UA70535U (ru) Способ диагностики стресс-индуцированной кардиомиопатии у детей
UA89111U (uk) Спосіб лікування антифосфоліпідного синдрому
UA65684U (ru) Способ определения повышенного уровня сенсибилизации организма
UA98362U (uk) Спосіб визначення типу око-серцевого рефлексу

Legal Events

Date Code Title Description
FG Grant or registration